Robust volume growth powers Tata Motors in Q2, but input cost pressures loom
Tata Motors moved higher in a quarterly results development.
· LiveMint Markets
A 42% revenue surge in Q2 helped Tata Motors offset margin pressures, though surging commodity costs and higher interest rates threaten near-term earnings.
The analysis
Tata Motors reported movement of 42%. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is -1.0% on the day at ₹396.35, and has returned -4.5% over three months. It sits 22% below its 52-week high. The auto sector has moved -7.7% over the same period, so Tata Motors is running 3.2 points ahead of its peers.
This is an Input cost / crude event. India imports most of its crude, so input costs pass through to margins downstream and to the rupee. Producers and consumers of the same input move in opposite directions. On the day the stock is -1.0%, so a modest reaction.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- In focus: Tata Motors (TMCV), in Auto.
- Over three months: Tata Motors -4.5% against Auto -7.7% (3.2 points ahead).
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Tata MotorsTMCV · Auto | ₹396.35 | -1.0% | -6.0% | -4.5% | -21.6% | 1.5× | — |
Auto
1M -5.8% · 3M -7.7%
Tata Motors
Prices as of 30 Oct 2026, 16:11 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Tata Motors completes Iveco takeover with 89.42% stake, buyout continues
Maruti Q2FY27 results: Net profit declines 26.36% to ₹2,466.1 crore
Hyundai Motor shares jump 6% even as Q2 net profit declines 24% YoY. Why Nomura, other brokerages remain bullish?
Meesho Q2 Results: Loss narrows to Rs 132 crore YoY, revenue rises 34%
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings